WO2001070997A3 - Regulation of human leucine aminopeptidase-like enzyme - Google Patents
Regulation of human leucine aminopeptidase-like enzyme Download PDFInfo
- Publication number
- WO2001070997A3 WO2001070997A3 PCT/EP2001/003331 EP0103331W WO0170997A3 WO 2001070997 A3 WO2001070997 A3 WO 2001070997A3 EP 0103331 W EP0103331 W EP 0103331W WO 0170997 A3 WO0170997 A3 WO 0170997A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- leucine aminopeptidase
- regulation
- enzyme
- human leucine
- reagents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01915412A EP1268814A2 (en) | 2000-03-24 | 2001-03-23 | Regulation of human leucine aminopeptidase-like enzyme |
| AU2001242512A AU2001242512A1 (en) | 2000-03-24 | 2001-03-23 | Regulation of human leucine aminopeptidase-like enzyme |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19171600P | 2000-03-24 | 2000-03-24 | |
| US60/191,716 | 2000-03-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001070997A2 WO2001070997A2 (en) | 2001-09-27 |
| WO2001070997A3 true WO2001070997A3 (en) | 2002-02-28 |
Family
ID=22706648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2001/003331 Ceased WO2001070997A2 (en) | 2000-03-24 | 2001-03-23 | Regulation of human leucine aminopeptidase-like enzyme |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1268814A2 (en) |
| AU (1) | AU2001242512A1 (en) |
| WO (1) | WO2001070997A2 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0535241A1 (en) * | 1991-04-08 | 1993-04-07 | Suntory Limited | Novel leucine aminopeptidase |
-
2001
- 2001-03-23 EP EP01915412A patent/EP1268814A2/en not_active Withdrawn
- 2001-03-23 WO PCT/EP2001/003331 patent/WO2001070997A2/en not_active Ceased
- 2001-03-23 AU AU2001242512A patent/AU2001242512A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0535241A1 (en) * | 1991-04-08 | 1993-04-07 | Suntory Limited | Novel leucine aminopeptidase |
Non-Patent Citations (5)
| Title |
|---|
| DATABASE EMBL SEQUENCE LIBRARY 12 April 1997 (1997-04-12), NCI-CGAP: ""National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index http://www.ncbi.nlm.nih.gov/ncicgap";", XP002182943 * |
| DATABASE EMBL SEQUENCE LIBRARY 13 June 1997 (1997-06-13), HILLIER, L., ET AL.: "WashU-Merck EST project 1997", XP002182942 * |
| DATABASE EMBL SEQUENCE LIBRARY 14 March 1995 (1995-03-14), NONE: ""Genome sequence of the nematode C. elegans: a platform for investigating biology. The C. elegans Sequencing Consortium" - Caenorhabditis elegans cosmid B0495, complete sequence", XP002182941 * |
| DATABASE SWALL-DATABASE 1 November 1997 (1997-11-01), KIRSTEN, J.: "HYPOTHETICAL 98.3 KDA PROTEIN B0495.7 IN CHROMOSOME II. - Caenorhabditis elegans.", XP002182940 * |
| HATTORI AKIRA ET AL: "Molecular cloning of adipocyte-derived leucine aminopeptidase highly related to placental leucine aminopeptidase/oxytocinase", JOURNAL OF BIOCHEMISTRY, JAPANESE BIOCHEMICAL SOCIETY, TOKYO, JP, vol. 125, no. 5, May 1999 (1999-05-01), pages 931 - 938, XP002155174, ISSN: 0021-924X * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1268814A2 (en) | 2003-01-02 |
| AU2001242512A1 (en) | 2001-10-03 |
| WO2001070997A2 (en) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002042445A3 (en) | Differentiated cells suitable for human therapy | |
| WO2002061090A3 (en) | Prokaryotically produced antibodies and uses thereof | |
| WO2003018771A3 (en) | A system for antibody expression and assembly | |
| WO2002074979A3 (en) | Expression profiles and methods of use | |
| WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
| WO2001083782A3 (en) | Novel proteases | |
| ATE174599T1 (en) | BINDING COMPETENT OLIGOMERS CONTAINING 2',5' BONDS | |
| GB0309765D0 (en) | A cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses. | |
| WO2002053170A3 (en) | Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo | |
| WO2002049593A3 (en) | Use of dna repair enzymes as mmp-1 inhibitors | |
| WO1998051799A1 (en) | Novel differentiation inhibitor | |
| WO2004098634A3 (en) | Protein arginine n-methyltransferase 2 (prmt-2) | |
| WO2002042326A8 (en) | A method of expression and agents identified thereby | |
| WO2000009553A3 (en) | Antimicrobial peptides isolated from the skin of american frogs | |
| WO1998059040A3 (en) | Human catalytic telomerase sub-unit and its diagnostic and therapeutic use | |
| EP1236465A3 (en) | Use of legume products for the treatment of external aggressions | |
| WO2000037487A8 (en) | αvβ6 INTEGRIN INHIBITORS | |
| WO2001036465A3 (en) | Human zven proteins | |
| WO2003044037A3 (en) | Process for the manufacture of human mononuclear phagocytic leukocytes | |
| WO2001070997A3 (en) | Regulation of human leucine aminopeptidase-like enzyme | |
| WO2023205793A3 (en) | Siglec-8 binding proteins and uses thereof | |
| MXPA03011622A (en) | Use of glycoprotein for the treatment and re-epithelialisation of wounds. | |
| MY132553A (en) | Methods of making hiv-protease inhibitors and intermediates for making hiv-protease inhibitors | |
| IL129922A0 (en) | Tissue specific expression of retinoblastoma protein | |
| WO2003070878A3 (en) | Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2001915412 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 10239422 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 2001915412 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 2001915412 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |